Literature DB >> 16092550

Role of alcohol and smoking in diagnostic delay of head and neck cancer patients.

Xavier Brouha1, Debbie Tromp, Gert-Jan Hordijk, Jacques Winnubst, Rob De Leeuw.   

Abstract

CONCLUSIONS: This study shows that heavy drinking is a risk factor for prolonged delay in presenting with head and neck cancer and for presenting with a large tumour in the head and neck region. Excessive smoking is only a risk factor for being diagnosed with a large tumour, although there is a weak association between smoking and prolonged diagnostic delay.
OBJECTIVE: It is reasonable to assume that prolonged delay in presenting with head and neck cancer is associated with an advanced stage of cancer at diagnosis. In this study we analysed the effects of drinking and smoking habits on diagnostic delay and the T stage of the tumour at diagnosis.
MATERIAL AND METHODS: A total of 427 patients with newly diagnosed head and neck carcinomas were eligible for this study. Of these, 306 (72%) actually participated: 134 (77%) with an oral tumour; 117 (69%) with a larynx tumour; and 55 (65%) with a pharynx tumour. Diagnostic delay was defined as a period of >30 days between the appearance of the first tumour-related symptoms and the first visit to a physician. T3 4 tumours were defined as advanced tumours. Drinking behaviour was classified into three types: light (0 2 drinks/day); moderate (3 4 drinks/day); and heavy ( >4 drinks/day). Smoking habits were classified into 4 types: never; stopped; light (0 20 cigarettes/day); and heavy (>20 cigarettes/day).
RESULTS: Logistic regression showed that there were significantly more heavy than light drinkers [p = 0.04; odds ratio (OR) 1.8; 95% CI 1.0-3.1] in the delay group than in the non-delay group. Light smokers showed a tendency towards prolonged delay (p = 0.06; OR 2.2; 95% CI 1.0-5.0). Both heavy drinking (p = 0.01; OR 2.0; 95% CI 1.2-3.6) and heavy smoking (p = 0.03; OR 3.1; 95% CI 1.1-8.4) were risk factors for a patient to be diagnosed with a large tumour.

Entities:  

Mesh:

Year:  2005        PMID: 16092550     DOI: 10.1080/00016480510028456

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  10 in total

Review 1.  Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers.

Authors:  Muhammad M Fareed; Rizwan Ishtiaq; Thomas J Galloway
Journal:  Curr Treat Options Oncol       Date:  2018-03-12

2.  Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

Authors:  Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Brian L Egleston; Lora S Wang; Ranee Mehra; Douglas B Flieder; John A Ridge
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

3.  Nitric oxide synthase 2 (NOS2) expression in histologically normal margins of oral squamous cell carcinoma.

Authors:  Rosana Morelatto; María-Elina Itoiz; Natalia Guiñazú; Daniel Piccini; Susana Gea; Silvia López-de Blanc
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-05-01

4.  Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA).

Authors:  Véronique Christophe; Tanguy Leroy; Mélanie Seillier; Camille Duthilleul; Morbize Julieron; Stéphanie Clisant; Jérôme Foncel; Fanny Vallet; Jean-Louis Lefebvre
Journal:  BMJ Open       Date:  2014-07-25       Impact factor: 2.692

5.  Lifestyle, socioeconomic status and healthcare seeking among women with gynaecological cancer alarm symptoms: a combined questionnaire-based and register-based population study.

Authors:  Kirubakaran Balasubramaniam; Sandra Elnegaard; Sanne Rasmussen; Peter Fentz Haastrup; René dePont Christensen; Jens Søndergaard; Dorte Ejg Jarbøl
Journal:  BMJ Open       Date:  2018-07-05       Impact factor: 2.692

6.  Factors influencing patient and health care delays in Oropharyngeal Cancer.

Authors:  Markus Nieminen; Timo Atula; Leif Bäck; Antti Mäkitie; Lauri Jouhi; Katri Aro
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-04-23

7.  Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma.

Authors:  Andreas Knopf; Simon Teutsch; Henning Bier
Journal:  BMC Health Serv Res       Date:  2021-01-08       Impact factor: 2.655

Review 8.  Challenges in the Early Diagnosis of Oral Cancer, Evidence Gaps and Strategies for Improvement: A Scoping Review of Systematic Reviews.

Authors:  Miguel Ángel González-Moles; Manuel Aguilar-Ruiz; Pablo Ramos-García
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

9.  Significant differences in demographic, clinical, and pathological features in relation to smoking and alcohol consumption among 1,633 head and neck cancer patients.

Authors:  Raquel Ajub Moyses; Rossana Verónica Mendoza López; Patrícia Maluf Cury; Sheila Aparecida Coelho Siqueira; Otávio Alberto Curioni; José Francisco de Gois Filho; David Livingstone Alves Figueiredo; Eloiza Helena Tajara; Pedro Michaluart
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

10.  Impact of Delay on Hospitalization in Older Patients With Head and Neck Cancer: A Multicenter Study.

Authors:  Rosanne C Schoonbeek; Suzanne Festen; Roza Rashid; Boukje A C van Dijk; György B Halmos; Lilly-Ann van der Velden
Journal:  Otolaryngol Head Neck Surg       Date:  2022-01-19       Impact factor: 5.591

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.